The Female Health Company / Veru Healthcare Reports  Successful Stage 1 of the Clinical Trial to Evaluate Bioequivalence Between Tamsulosin DRS, FLOMAX; Planned NDA Filing Under 505(b)(2) Regulatory Pathway On Track